Skip to content

Temporal Trends of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea

Temporal Trends in the Incidence, Treatment Patterns, and Outcomes of COronary Artery Disease and PEripheral Artery Disease (COPE) in Korea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04834843
Acronym
COPE registry
Enrollment
700000
Registered
2021-04-08
Start date
2009-01-01
Completion date
2020-12-31
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Coronary Artery Disease, Peripheral Artery Disease

Brief summary

Cardiovascular disease (CVD) is caused by atherosclerosis of the artery and is classified into coronary artery disease, cerebrovascular disease, and peripheral arterial disease, depending on the location of the artery and the target organs. However, since CVD share a similar pathophysiology and the probability of incidence of other CVD in CVD patients is very high. It is thought that CVD incidence and mortality can be reduced by predicting the degree of incidence of other CVD in CVD patients. The aim of this study is to investigate the incidence and mortality of other CVD diseases in CVD patients.

Interventions

Observational study, no intervention

Sponsors

Wonju Severance Christian Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Koreans who diagnosed with coronary artery disease between 2009 and 2018 * Koreans who diagnosed with peripheral artery disease between 2009 and 2018 * Koreans who diagnosed with cerebrovascular disease between 2009 and 2018 * more than 18 years old

Exclusion criteria

* less than 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Incidence of coronary artery disease, cerebrovascular disease, peripheral arterial diseaseUp to 10 yearsAmong all Koreans, percentage (%) of patients with a history of being diagnosed with CVD and underwent in-hospital treatment

Secondary

MeasureTime frameDescription
1-year mortalityUp to 1 yearThe percentage (%) of any CVD related mortality

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026